☰

Jenny J. Kim, Ph.D. - Publications

Affiliations: 
2001 University of California, Los Angeles, Los Angeles, CA 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Do TH, Ma F, Andrade PR, Teles R, de Andrade Silva BJ, Hu C, Espinoza A, Hsu JE, Cho CS, Kim M, Xi J, Xing X, Plazyo O, Tsoi LC, Cheng C, ... Kim J, et al. TREM2 macrophages induced by human lipids drive inflammation in acne lesions. Science Immunology. 7: eabo2787. PMID 35867799 DOI: 10.1126/sciimmunol.abo2787  0.478
2019 Tran PT, Evron E, Qin M, Dohil I, Baugh A, Agak G, Kim J. 452 Cutibacterium acnes carbohydrates from multiple phylotypes induce IL-17: A potential ligand implicated in acne disease pathogenesis Journal of Investigative Dermatology. 139. DOI: 10.1016/J.Jid.2019.03.528  0.351
2019 Agak G, Ceja-Garcia N, Dang P, Shah D, Teles R, Mouton A, Morselli M, Qin M, Kim J, Pellegrini M, Modlin R. 070 Antimicrobial Th17CTL targeting both Gram-positive and Gram-negative bacteria Journal of Investigative Dermatology. 139: S12. DOI: 10.1016/J.Jid.2019.03.146  0.451
2018 Evron E, Qin M, Agak GW, Kim J. 1040 Propionibacterium acnes carbohydrates from acne associated phylotypes induce distinct inflammatory response in comparison to carbohydrates from healthy phylotypes: A potential ligand implicated in acne disease pathogenesis Journal of Investigative Dermatology. 138. DOI: 10.1016/J.Jid.2018.03.1052  0.332
2018 Marinelli L, Do T, Kim J, Modlin R. 1016 Lysis by bacteriophages can modulate Cutibacterium (formerly Propionibacterium) acnes-induced immune responses Journal of Investigative Dermatology. 138: S172. DOI: 10.1016/J.Jid.2018.03.1028  0.509
2018 Agak G, Qin M, Ceja-Garcia N, Ouyang K, Teles R, Mouton A, Morselli M, Kim J, Pellegrini M, Modlin R. 051 Antimicrobial activity of cytolytic Th17 cells targeting propionibacterium acnes Journal of Investigative Dermatology. 138: S9. DOI: 10.1016/J.Jid.2018.03.055  0.496
2017 Park AJ, Agak GW, Qin M, Hisaw LD, Pirouz A, Kao S, Marinelli LJ, Garbán HJ, Thiboutot D, Liu PT, Kim J. G2A Attenuates Propionibacterium acnes Induction of Inflammatory Cytokines in Human Monocytes. Annals of Dermatology. 29: 688-698. PMID 29200756 DOI: 10.5021/Ad.2017.29.6.688  0.563
2017 Chesney J, Puzanov I, Collichio F, Singh P, Milhem MM, Glaspy J, Hamid O, Ross M, Friedlander P, Garbe C, Logan TF, Hauschild A, Lebbé C, Chen L, Kim JJ, et al. Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017737379. PMID 28981385 DOI: 10.1200/JCO.2017.73.7379  0.648
2017 Agak GW, Kao S, Ouyang K, Qin M, Moon D, Butt A, Kim J. Phenotype and antimicrobial activity of Th17 cells induced by Propionibacterium acnes strains associated with healthy and acne skin. The Journal of Investigative Dermatology. PMID 28864077 DOI: 10.1016/J.Jid.2017.07.842  0.387
2016 Yu Y, Champer J, Agak GW, Kao S, Modlin RL, Kim J. Different Propionibacterium acnes phylotypes induce distinct immune responses and express unique surface and secreted proteomes. The Journal of Investigative Dermatology. PMID 27377696 DOI: 10.1016/J.Jid.2016.06.615  0.525
2015 Qin M, Landriscina A, Rosen J, Wei G, Kao S, Olcott W, Agak GW, Paz KB, Bonventre J, Clendaniel A, Harper S, Adler B, Krausz A, Friedman J, Nosanchuk J, ... Kim J, et al. Nitric Oxide Releasing Nanoparticles Prevent Propionibacterium acnes Induced Inflammation by both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response. The Journal of Investigative Dermatology. PMID 26172313 DOI: 10.1038/Jid.2015.277  0.385
2014 Agak GW, Qin M, Nobe J, Kim MH, Krutzik SR, Tristan GR, Elashoff D, Garbán HJ, Kim J. Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D. The Journal of Investigative Dermatology. 134: 366-73. PMID 23924903 DOI: 10.1038/Jid.2013.334  0.701
2014 Qin M, Pirouz A, Kim MH, Krutzik SR, Garbán HJ, Kim J. Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes. The Journal of Investigative Dermatology. 134: 381-8. PMID 23884315 DOI: 10.1038/Jid.2013.309  0.702
2013 Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, Modlin RL, Miller JF, Sodergren E, Craft N, Weinstock GM, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. The Journal of Investigative Dermatology. 133: 2152-60. PMID 23337890 DOI: 10.1038/Jid.2013.21  0.482
2013 Friedman AJ, Phan J, Schairer DO, Champer J, Qin M, Pirouz A, Blecher-Paz K, Oren A, Liu PT, Modlin RL, Kim J. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens. The Journal of Investigative Dermatology. 133: 1231-9. PMID 23190896 DOI: 10.1038/Jid.2012.399  0.623
2012 Marinelli LJ, Fitz-Gibbon S, Hayes C, Bowman C, Inkeles M, Loncaric A, Russell DA, Jacobs-Sera D, Cokus S, Pellegrini M, Kim J, Miller JF, Hatfull GF, Modlin RL. Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates. Mbio. 3. PMID 23015740 DOI: 10.1128/Mbio.00279-12  0.507
2011 Cho JS, Zussman J, Donegan NP, Ramos RI, Garcia NC, Uslan DZ, Iwakura Y, Simon SI, Cheung AL, Modlin RL, Kim J, Miller LS. Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections. The Journal of Investigative Dermatology. 131: 907-15. PMID 21191403 DOI: 10.1038/Jid.2010.417  0.512
2008 Jalian HR, Liu PT, Kanchanapoomi M, Phan JN, Legaspi AJ, Kim J. All-trans retinoic acid shifts Propionibacterium acnes-induced matrix degradation expression profile toward matrix preservation in human monocytes. The Journal of Investigative Dermatology. 128: 2777-82. PMID 18563181 DOI: 10.1038/Jid.2008.155  0.525
2008 Liu PT, Phan J, Tang D, Kanchanapoomi M, Hall B, Krutzik SR, Kim J. CD209(+) macrophages mediate host defense against Propionibacterium acnes. Journal of Immunology (Baltimore, Md. : 1950). 180: 4919-23. PMID 18354216 DOI: 10.4049/Jimmunol.180.7.4919  0.747
2006 McInturff JE, Kim J. The role of Toll: How therapies targeting Toll-like receptors treat skin diseases Drug Discovery Today: Therapeutic Strategies. 3: 75-80. DOI: 10.1016/J.Ddstr.2006.02.008  0.369
2005 Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 211: 193-198. PMID 16205063 DOI: 10.1159/000087011  0.361
2005 McInturff JE, Wang SJ, Machleidt T, Lin TR, Oren A, Hertz CJ, Krutzik SR, Hart S, Zeh K, Anderson DH, Gallo RL, Modlin RL, Kim J. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. The Journal of Investigative Dermatology. 125: 256-63. PMID 16098035 DOI: 10.1111/J.0022-202X.2005.23805.X  0.683
2005 McInturff JE, Kim J. The role of toll-like receptors in the pathophysiology of acne. Seminars in Cutaneous Medicine and Surgery. 24: 73-78. PMID 16092794 DOI: 10.1016/J.Sder.2005.03.002  0.388
2005 McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. The Journal of Investigative Dermatology. 125: 1-8. PMID 15982296 DOI: 10.1111/J.0022-202X.2004.23459.X  0.573
2005 Miller LS, Sørensen OE, Liu PT, Jalian HR, Eshtiaghpour D, Behmanesh BE, Chung W, Starner TD, Kim J, Sieling PA, Ganz T, Modlin RL. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. Journal of Immunology (Baltimore, Md. : 1950). 174: 6137-43. PMID 15879109 DOI: 10.4049/Jimmunol.174.10.6137  0.646
2005 Liu PT, Krutzik SR, Kim J, Modlin RL. Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. Journal of Immunology (Baltimore, Md. : 1950). 174: 2467-70. PMID 15728448 DOI: 10.4049/Jimmunol.174.5.2467  0.757
2003 Arora T, Liu B, He H, Kim J, Murphy TL, Murphy KM, Modlin RL, Shuai K. PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4. The Journal of Biological Chemistry. 278: 21327-30. PMID 12716907 DOI: 10.1074/Jbc.C300119200  0.506
2002 Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Journal of Immunology (Baltimore, Md. : 1950). 169: 1535-41. PMID 12133981 DOI: 10.4049/Jimmunol.169.3.1535  0.748
2001 Kim J, Uyemura K, Van Dyke MK, Legaspi AJ, Rea TH, Shuai K, Modlin RL. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. Journal of Immunology (Baltimore, Md. : 1950). 167: 779-86. PMID 11441083 DOI: 10.4049/Jimmunol.167.2.779  0.556
2000 Yamauchi PS, Bleharski JR, Uyemura K, Kim J, Sieling PA, Miller A, Brightbill H, Schlienger K, Rea TH, Modlin RL. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy. Journal of Immunology (Baltimore, Md. : 1950). 165: 1506-12. PMID 10903757 DOI: 10.4049/Jimmunol.165.3.1506  0.71
Show low-probability matches.